U.S. pharma big copyright scrapped two experimental weight loss products last year—a once-day by day tablet, lotiglipron, because of elevated liver enzymes plus a two times-every day tablet, danuglipron, due to potent Negative effects—but CEO Albert Bourla has said the company is decided to “Enjoy and acquire” inside the weight problems Are